NCT04860934

Brief Summary

Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. With the goal of, complete resection, major complications during tumor removal are usually caused by damage to the brain stem and injury to the lower cranial nerves.It has been reported that those children present Ataxia after resection. So the purpose of this study is to investigate the effectiveness of using a selected dual-task- training program to improve postural stability in those Children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 21, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 27, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

March 21, 2021

Last Update Submit

November 7, 2022

Conditions

Keywords

AtaxiaMedulloblastoma Resectionposterior fossa tumorphysical activityDual Task TrainingChildhood Cancer

Outcome Measures

Primary Outcomes (1)

  • Dual Task Training program

    Determining the efficacy of "Dual-Task Training in children with ataxia after Medulloblastoma Resection regarding "Static Balance" and "Dynamic Balance" will be assessed with HUMAC Balance system as indicators of Postural Control

    8 Weeks

Secondary Outcomes (1)

  • Ataxia after Medulloblastoma Resection

    8 Weeks

Other Outcomes (2)

  • Balance system in children with ataxia after Medulloblastoma Resection

    8 Weeks

  • ADL (activity of daily living) in children with ataxia after Medulloblastoma Resection

    8 Weeks

Study Arms (2)

Physical therapy

ACTIVE COMPARATOR

Each child in this group will receive the selected physical therapy program which include mobility exercises, strengthening exercises, balance exercises, gait training exercises, and exercises to improve physical conditioning for one-hour session three times weekly for 8 successive weeks

Behavioral: Control Group

Physical therapy + Dual Task Training Program

EXPERIMENTAL

Each child in this group will perform one-hour session consist of two tasks (cognitive and balance task) in addition to the selected physical therapy program as control group three times weekly for 8 successive weeks.

Behavioral: Dual Task Training Program GroupBehavioral: Control Group

Interventions

Fifteen patients will receive Dual Task Training Program. Total Period: 8 Weeks.

Physical therapy + Dual Task Training Program
Control GroupBEHAVIORAL

Each child in this group will receive the selected physical therapy program which include mobility exercises, strengthening exercises, balance exercises, gait training exercises, and exercises to improve physical conditioning for one-hour session three times weekly for 8 successive weeks.

Physical therapyPhysical therapy + Dual Task Training Program

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age range from (5-10 years).
  • Severity of ataxia will be from 15-30 by SARA scale.
  • Children after 2 months of medulloblastoma resection.
  • They can stand and walk with minimal support.
  • They have good cognition, compliance, and ability to understand and execute test instructions.
  • Children receiving radiotherapy and chemotherapy sessions
  • They are medically stable

You may not qualify if:

  • Children will be excluded from the study if they have
  • Any neuromuscular disorder.
  • Visual impairment.
  • Cognitive problem
  • Convulsion.
  • Peripheral neuropathy due to chemotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Cancer Hospital Egypt 57357

Cairo, 11441, Egypt

Location

Related Publications (1)

  • Selim FM, Elshafey MA, El-Ayadi MM, Albeltagi DM, Ali MS. Efficacy of dual-task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial. Pediatr Blood Cancer. 2023 Nov;70(11):e30613. doi: 10.1002/pbc.30613. Epub 2023 Aug 10.

MeSH Terms

Conditions

MedulloblastomaNeoplasmsAtaxiaInfratentorial NeoplasmsMotor Activity

Interventions

Control Groups

Condition Hierarchy (Ancestors)

GliomaNeoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeuroectodermal Tumors, PrimitiveNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueDyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain NeoplasmsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteBrain DiseasesCentral Nervous System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Fatma Mostafa Sedeek, BSc

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental controlled randomization using Block Stratified Randomized Software program, after obtaining informed consent from illegible patient or his caregiver.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2021

First Posted

April 27, 2021

Study Start

March 15, 2021

Primary Completion

November 15, 2021

Study Completion

November 30, 2021

Last Updated

November 8, 2022

Record last verified: 2022-11

Locations